drug

DAR 0-100A

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Antonia New
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
A D1 Agonist For Working Memory
NCT02507206Phase 2Completed

KOLs & investigators

1
Antonia S. New, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Antonia New
company
trial
A D1 Agonist For Working Memory
PHASE2
trial
indication
Delirium
indication
Schizotypal Personality Disorder
indication
Mental Disorders
indication
Cognition Disorders
indication
KOL
Antonia S. New, MD
KOL score —
person